Imfinzi 120mg Injection contains Durvalumab, a monoclonal antibody used in the treatment of certain types of cancers, including non-small cell lung cancer and urothelial carcinoma. 

Brand Name: Imfinzi

Composition: Durvalumab

Mechanism of Action:

Imfinzi is an inhibitor of programmed death-ligand 1 (PD-L1) that strengthens the immune system's defenses against cancer. By expressing PD-L1, which attaches to the PD-1 receptor on T-cells and inhibits their function, tumor cells frequently avoid immunological detection. By blocking this connection, durvalumab restores T-cell activation and makes it possible for the immune system to identify and eliminate cancer cells efficiently.

Uses:

• Non-Small Cell Lung Cancer
• Small Cell Lung Cancer
• Biliary Tract Cancer

Dosage and Administration:

Give the infusion intravenously over a period of sixty minutes. Avoid giving it as a quick IV push or bolus.

Side Effects:

• Fatigue
• Cough
• Diarrhea
• Nausea
• Vomiting
• Rash
• Decreased appetite

Safety Advises:

Liver  

Periodic tests for liver function are recommended as the drug can cause toxicity, especially in patients with pre-existing conditions. Kindly speak with your healthcare provider.

Kidney  

Periodic tests for kidney function are recommended as the drug can cause toxicity, especially in patients with pre-existing conditions. Kindly speak with your healthcare provider.

Pregnancy  

Imfinzi is contraindicated in pregnancy due to the risk of fetal harm. Kindly speak with your healthcare provider.

Breast Feeding  

Breastfeeding should be avoided, as the drug can be excreted in breast milk. Kindly speak with your healthcare provider.

Storage:

Store Imfinzi Injection in the refrigerator at 2-8°C, protected from light, and avoid freezing.

How to use this Medication?

In a hospital or other medical institution, a doctor or nurse will administer a liquid injection of durvalumab into a vein over the course of 60 minutes. For as long as your doctor advises you to undergo treatment, it is typically injected once every two weeks, once every three weeks, or once every four weeks. The kind of cancer you have and how your body reacts to the drug will determine the dosage regimen.

Since durvalumab injections might result in severe infusion responses, you will be closely watched both during and after the procedure. If you get symptoms like chills, a rash, trouble breathing, lightheadedness, or swelling in your face, let your doctor know right away.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: AstraZeneca

Address: Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore

Country of origin: United kingdom